0009

Hunan Jingfeng Pharmaceutical Co.,Ltd. 000908

Market Open
11 Sep, 05:59
XSHE XSHE
¥
4. 34
-0.23
-5.03%
¥
3.16B Market Cap
- P/E Ratio
0.04% Div Yield
32,329,000 Volume
- Eps
¥ 4.57
Previous Close
Day Range
4.34 4.4
Year Range
0.72 5.07

000908 Chart

Hunan Jingfeng Pharmaceutical Co.,Ltd. Profile

Drug Manufacturers—General Industry
Healthcare Sector
- CEO
XSHE Exchange
CNE000000Y11 ISIN
China Country
572 Employees
- Last Dividend
23 Jun 2016 Last Split
- IPO Date

Overview

Hunan Jingfeng Pharmaceutical Co., Ltd., established in 2003 and based in Shanghai, China, is engaged in the manufacturing and sale of chemical drugs and biological agents across the country. The company has carved out a niche in the pharmaceutical industry through its focus on sodium hyaluronate injection, primarily used in orthopedics and surgery applications. Expanding its portfolio, Hunan Jingfeng Pharmaceutical also invests in the research and development of novel therapeutics targeting major health concerns such as tumors, cancer, and cardiovascular diseases. In addition to its product offerings, the company extends its expertise by providing comprehensive Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services, leveraging its advanced technological capabilities and industry experience.

Products and Services

  • Sodium Hyaluronate Injection: The flagship product of Hunan Jingfeng Pharmaceutical, designed for orthopedic and surgical use, exemplifies the company's commitment to advancing medical care through innovative treatments.
  • Ophthalmology Products: The company offers a range of products tailored for eye health, underscoring its dedication to addressing a wide spectrum of medical needs.
  • API (Active Pharmaceutical Ingredients): Hunan Jingfeng Pharmaceutical provides high-quality active pharmaceutical ingredients, demonstrating its capability in supporting the broader pharmaceutical industry with essential components for drug development and manufacturing.
  • Anti-Tumor, Cancer, and Cardiovascular Drug R&D: Engaged in the research and development of cutting-edge drugs to combat tumors, cancer, and cardiovascular diseases, the company takes an active part in the global fight against some of the most challenging health issues.
  • Skin Care Products: Expanding its product range beyond pharmaceuticals, Hunan Jingfeng Pharmaceutical also offers skin care products, emphasizing its aim to enhance overall well-being and quality of life.
  • CDMO/CMO Services: With comprehensive Contract Development and Manufacturing Organization (CDMO) and Contract Manufacturing Organization (CMO) services, Hunan Jingfeng Pharmaceutical positions itself as a versatile partner in the pharmaceutical and biotechnology sectors, offering end-to-end solutions from development to manufacturing.

Contact Information

Address: No. 2288 Shitai Road
Phone: 86 21 6686 1001